Publication | Closed Access

Use of flash glucose monitoring system in assessing safety of the SGLT2 inhibitors during Ramadan fasting in high risk insulin treated patients with type 2 diabetes

Metabolic SyndromeDiabetes ManagementHigh Risk InsulinMedicineInsulin ManagementDiabetesType 2Blood Glucose MonitoringDiabetes MellitusPharmacologySglt2 Inhibitors